| 顾云娟，贾伟平.降糖药物与恶性肿瘤关系的研究进展[J].中华流行病学杂志,2011,32(11):1170-1173 |
| 降糖药物与恶性肿瘤关系的研究进展 |
| The relationship of antidiabetic drugs and cancer risk |
| 收稿日期:2011-05-16 出版日期:2014-09-18 |
| DOI： |
| 中文关键词: 糖尿病 恶性肿瘤 降糖药物 |
| 英文关键词: Diabetes Neoplasms Antidiabetic drugs |
| 基金项目:上海市科学计划委员会重大项目(09DZ1950202) |
|
| 摘要点击次数: 2334 |
| 全文下载次数: 1436 |
| 中文摘要: |
| 有研究认为糖尿病与某些肿瘤的发生相关。而长期的糖尿病病程中各种降糖药的使用是否也参与其中，目前还不明确 |
| 英文摘要: |
| objective To analyze the risk factors related to survival time of advanced non- small cell lung cancer(NSCLC)and to establish a prediction model on survival time.Methods From 2004-2006.1 84 patients with advanced NSCLC were enrolled in the Affiliated Hospital to the Nantong Midical College.Related risk factors were analyzed.using the Buckley-James model.Both actual and predicted survival time were compared by log.rank test.Results Through Buckley-James model analysis，data showed that loS，clinical stage，treatment and pre-treatment hemoglobin were main influencing factors on survival time.Regression equation appeared to be InMONTH= 0.0108 KPS+0.0238 HB+0.4614 IIIb+0.8027Ⅲa+0.3869(radiotherapy+chemotherapy)+0.507 (radiotherapy+operation)+0.6082(chemotherapy+operation)一2.098.There was no statistical difference between the prediction and the actual models of survival time by log-rank test(P----0.575> O.05).Conclusion KPS，clinical stage，treatment and pre.treatment hemoglobin might be associated. Both the prognosis of patients with advanced NSCLC and the prediction model seemed to have practical signiflcances. |
|
查看全文
Html全文
查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
